DOCSLIB.ORG

Supplementary Table 1A. Variants Detected in Breast Cancer-Affected

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Supplementary Table 1A. Variants Detected in Breast Cancer-Affected Supplementary table 1A. Variants detected in breast cancer-affected members of family 1 Gene DESCRIPTION KEGG Pathway ID KEGG Pathway Description Chr Position RefSeq ExonChange Func ESP6500 1000 Genome dbSNP137 PolyPhen2 Distribution Frequency Nucleotide Amino acid Score Prediction 1 2 3 4 6 7 8 GPRIN1 G protein regulated inducer of neurite outgrowth 1 chr5 176026123 NM_052899 exon2 c.T713C p.L238S exonic 0.91 D -+++++- 5 ZNF335 zinc finger protein 335 chr20 44598182 NM_022095 exon3 c.T350C p.M117T exonic 1.00 D -+++--+ 4 LRRC66 leucine rich repeat containing 66 chr4 52861746 NM_001024611 exon4 c.A1442T p.D481V exonic 0.96 D --+++-+ 4 NBPF16 neuroblastoma breakpoint family, member 16 chr1 148756665 NM_001102663 exon16 c.G1994T p.G665V exonic 0.92 D ++-++-- 4 GPR116 G protein-coupled receptor 116 chr6 46826012 NM_001098518 exon17 c.G3628C p.E1210Q exonic 1.00 D -+++--- 3 ANKRD20A1 ankyrin repeat domain 20 family, member A1 chr9 67934829 NM_001012419 exon4 c.G599A p.R200Q splicing 1.00 D --++--+ 3 RBMXL1 RNA binding motif protein, X-linked-like 1 chr1 89449011 NM_019610 exon2 c.C499G p.P167A exonic 1.00 D +---++- 3 COL12A1 collagen, type XII, alpha 1 chr6 75864212 NM_004370 exon17 c.A3485C p.D1162A exonic 0.85 D --+--++ 3 ANKRD20A1 ankyrin repeat domain 20 family, member A1 chr9 67935957 NM_001012419 exon5 c.C682A p.Q228K exonic 0.81 P -+-++-- 3 ITGB1BP1 integrin beta 1 binding protein 1 chr2 9546989 NM_022334 exon6 c.T427A p.S143T exonic 0.75 P -+++--- 3 AVIL advillin chr12 58197038 NM_006576 exon15 c.T1954C p.W652R exonic 1.00 D ----++- 2 MYH3 myosin, heavy chain 3, skeletal muscle, embryonic hsa05416 Viral myocarditis chr17 10533244 NM_002470 exon39 c.A5573G p.D1858G exonic 1.00 D -+-+--- 2 RNF215 ring finger protein 215 chr22 30775768 NM_001017981 exon8 c.A1043G p.H348R exonic 1.00 D --++--- 2 ANKRD44 ankyrin repeat domain 44 chr2 197986226 NM_001195144 exon8 c.G736A p.A246T exonic 0.99 D ----++- 2 ITPR2 inositol 1,4,5-trisphosphate receptor, type 2 hsa05010 Alzheimer's disease chr12 26839489 NM_002223 exon11 c.C1073T p.P358L exonic 0.99 D ----+-+ 2 USP28 ubiquitin specific peptidase 28 chr11 113683049 NM_020886 exon16 c.A1921G p.S641G exonic 0.99 D --++--- 2 ZNF417 zinc finger protein 417 chr19 58421230 NM_152475 exon3 c.A416G p.Q139R exonic 0.99 D -++---- 2 ZNF587 zinc finger protein 587 chr19 58370196 NM_001204817 exon3 c.A413G p.Q138R exonic 0.99 D -++---- 2 TIGD2 tigger transposable element derived 2 chr4 90034310 NM_145715 exon1 c.C185T p.T62I exonic 0.99 D ----+-+ 2 NUP35 nucleoporin 35kDa chr2 184016246 NM_138285 exon5 c.G408C p.M136I exonic 0.98 D ----++- 2 FLG filaggrin chr1 152276761 NM_002016 exon3 c.A10601G p.N3534S exonic 0.98 D +---+-- 2 GOLGA8A golgin A8 family, member A chr15 34677275 NM_181077 exon7 c.G541A p.A181T exonic 0.96 D --+---+ 2 TEX15 testis expressed 15 chr8 30702074 NM_031271 exon1 c.C4460T p.T1487I exonic 0.88 D ----++- 2 ANKRD20A2 ankyrin repeat domain 20 family, member A2 chr9 42377496 NM_001012419 exon5 c.C682A p.Q228K exonic 0.81 P -+----+ 2 ACADVL acyl-CoA dehydrogenase, very long chain hsa01100 Metabolic pathways chr17 7125576 NM_001033859 exon8 c.A767T p.K256M exonic 0.81 P -+-+--- 2 GOLGA8A golgin A8 family, member A chr15 34674259 NM_181077 exon14 c.C1363T p.R455C exonic 0.70 P ---+--+ 2 C11orf82 chromosome 11 open reading frame 82 chr11 82643815 NM_145018 exon6 c.T1435A p.L479I exonic 0.63 P --++--- 2 ARID4B AT rich interactive domain 4B (RBP1-like) chr1 235346016 NM_031371 exon19 c.C1960T p.H654Y exonic 0.47 P -++---- 2 ANKRD20A1 ankyrin repeat domain 20 family, member A1 chr9 67938656 NM_001012419 exon6 c.C791G p.S264X stopgain 0.57 --+++-- 3 ABCC6 ATP-binding cassette, sub-family C (CFTR/MRP), memberhsa02010 6 ABC transporters chr16 16269844 NM_001171 exon21 c.2591-1G>T splicing - - + + - - - 2 ALDOA aldolase A, fructose-bisphosphate hsa01100 Metabolic pathways chr16 30066250 splicing - - - - + - + 2 PINK1 PTEN induced putative kinase 1 hsa05012 Parkinson's disease chr1 20972051 NM_032409 exon5 c.960-2A>G splicing - - + + - - - 2 ANAPC1 anaphase promoting complex subunit 1 hsa04914 Progesterone-mediated oocyte maturation chr2 112573216 NM_022662 exon28 c.C3328T p.R1110C exonic 1.00 D -----+- 1 CTBP2 C-terminal binding protein 2 hsa05220 Chronic myeloid leukemia chr10 126683225 NM_022802 exon5 c.G2213C p.R738P exonic 1.00 D ---+--- 1 ECI2 enoyl-CoA delta isomerase 2 hsa04146 Peroxisome chr6 4130638 NM_001166010 exon4 c.C379T p.R127W exonic 1.00 D ---+--- 1 GTF2I general transcription factor IIi hsa03022 Basal transcription factors chr7 74163734 NM_001518 exon24 c.C2243T p.P748L exonic 1.00 D --+---- 1 IGSF10 immunoglobulin superfamily, member 10 chr3 151156303 NM_001178145 exon2 c.T127G p.C43G exonic 1.00 D -+----- 1 KRT80 keratin 80 chr12 52579353 NM_001081492 exon2 c.C319T p.R107C exonic 1.00 D ---+--- 1 MAS1L MAS1 oncogene-like chr6 29454897 NM_052967 exon1 c.G783T p.R261S exonic 1.00 D ---+--- 1 PABPC3 poly(A) binding protein, cytoplasmic 3 chr13 25670625 NM_030979 exon1 c.G289C p.G97R exonic 1.00 D -----+- 1 TTLL7 tubulin tyrosine ligase-like family, member 7 chr1 84386943 NM_024686 exon11 c.G1277A p.R426Q exonic 1.00 D +------ 1 ZFAND4 zinc finger, AN1-type domain 4 chr10 46147441 NM_001128324 exon4 c.C301T p.R101C exonic 1.00 D -----+- 1 DHX35 DEAH (Asp-Glu-Ala-His) box polypeptide 35 chr20 37647477 NM_001190809 exon14 c.C1340T p.P447L exonic 1.00 D +------ 1 ERBB2IP erbb2 interacting protein hsa04621 NOD-like receptor signaling pathway chr5 65370916 NM_001253698 exon22 c.A3698G p.H1233R exonic 1.00 D -+----- 1 FRYL FRY-like chr4 48559492 NM_015030 exon34 c.A4103G p.N1368S exonic 1.00 D ---+--- 1 KRBA2 KRAB-A domain containing 2 chr17 8273461 NM_213597 exon2 c.G470A p.R157H exonic 1.00 D ---+--- 1 PABPC3 poly(A) binding protein, cytoplasmic 3 chr13 25671456 NM_030979 exon1 c.C1120T p.R374C exonic 1.00 D ------+ 1 PROSER1 proline and serine rich 1 chr13 39600439 NM_170719 exon5 c.C389T p.P130L exonic 1.00 D +------ 1 TES testis derived transcript (3 LIM domains) chr7 115892471 NM_015641 exon6 c.T1018C p.Y340H exonic 1.00 D ----+-- 1 WDR52 WD repeat domain 52 chr3 113115390 NM_001164496 exon14 c.G1754A p.R585H exonic 1.00 D ----+-- 1 CTBP2 C-terminal binding protein 2 hsa05220 Chronic myeloid leukemia chr10 126683235 NM_022802 exon5 c.G2203T p.V735F exonic 1.00 D ---+--- 1 FRG1 FSHD region gene 1 chr4 190883081 NM_004477 exon8 c.T734G p.L245R exonic 1.00 D ----+-- 1 OR4M1 olfactory receptor, family 4, subfamily M, member 1 hsa04740 Olfactory transduction chr14 20249380 NM_001005500 exon1 c.T899G p.M300R exonic 1.00 D ---+--- 1 LGALS9 lectin, galactoside-binding, soluble, 9 chr17 25965331 NM_002308 exon2 c.G82A p.G28R exonic 1.00 D --+---- 1 PIWIL4 piwi-like RNA-mediated gene silencing 4 hsa04320 Dorso-ventral axis formation chr11 94310519 NM_152431 exon4 c.A374G p.Q125R exonic 1.00 D +------ 1 SPESP1 sperm equatorial segment protein 1 chr15 69238630 NM_145658 exon2 c.G757T p.D253Y exonic 1.00 D +------ 1 TBC1D15 TBC1 domain family, member 15 chr12 72311484 NM_001146213 exon13 c.A1408C p.N470H exonic 1.00 D ---+--- 1 ITPR3 inositol 1,4,5-trisphosphate receptor, type 3 hsa05010 Alzheimer's disease chr6 33659653 NM_002224 exon54 c.G7406T p.G2469V exonic 1.00 D +------ 1 FRG1 FSHD region gene 1 chr4 190883080 NM_004477 exon8 c.C733A p.L245M exonic 0.99 D ----+-- 1 PCDH18 protocadherin 18 chr4 138452524 NM_019035 exon1 c.A719G p.N240S exonic 0.99 D -+----- 1 SLC30A7 solute carrier family 30 (zinc transporter), member 7 chr1 101387306 NM_001144884 exon8 c.G751C p.V251L exonic 0.99 D -+----- 1 UNC5A unc-5 homolog A (C. elegans) hsa04360 Axon guidance chr5 176306444 NM_133369 exon14 c.G2318A p.R773Q exonic 0.99 D +------ 1 EIF4G2 eukaryotic translation initiation factor 4 gamma, 2 hsa05416 Viral myocarditis chr11 10823596 NM_001042559 exon13 c.G1299T p.Q433H splicing 0.99 D +------ 1 MMRN1 multimerin 1 chr4 90857440 NM_007351 exon6 c.C2609T p.T870I exonic 0.99 D ----+-- 1 PEAK1 pseudopodium-enriched atypical kinase 1 chr15 77472182 NM_024776 exon5 c.A2087C p.E696A exonic 0.99 D -+----- 1 RGPD5 RANBP2-like and GRIP domain containing 5 chr2 111325017 NM_005054 exon4 c.C341A p.A114E exonic 0.99 D ---+--- 1 SGPL1 sphingosine-1-phosphate lyase 1 hsa01100 Metabolic pathways chr10 72628128 NM_003901 exon8 c.A642G p.I214M exonic 0.99 D -----+- 1 GPRIN1 G protein regulated inducer of neurite outgrowth 1 chr5 176026136 NM_052899 exon2 c.G700T p.D234Y exonic 0.99 D ----+-- 1 CTTN cortactin hsa05131 Shigellosis chr11 70279803 NM_001184740 exon16 c.G1384A p.A462T exonic 0.99 D ---+--- 1 CYYR1 cysteine/tyrosine-rich 1 chr21 27938648 NM_052954 exon2 c.A113T p.Y38F exonic 0.99 D +------ 1 ARSD arylsulfatase D chrX 2833638 NM_001669 exon6 c.G959A p.G320D exonic 0.99 D ---+--- 1 KIF21A kinesin family member 21A chr12 39727028 NM_001173463 exon17 c.C2434T p.R812C exonic 0.98 D +------ 1 GZF1 GDNF-inducible zinc finger protein 1 chr20 23350809 NM_022482 exon5 c.G1867A p.E623K exonic 0.98 D ---+--- 1 ANKRD20A2 ankyrin repeat domain 20 family, member A2 chr9 42396440 NM_001012419 exon11 c.A1054G p.R352G exonic 0.98 D +------ 1 ANKRD20A2 ankyrin repeat domain 20 family, member A2 chr9 43105400 NM_001012419 exon11 c.A1054G p.R352G exonic 0.98 D +------ 1 ATP6AP2 ATPase, H+ transporting, lysosomal accessory protein 2 chrX 40448358 NM_005765 exon2 c.C158T p.S53F exonic 0.97 D +------ 1 CCDC86 coiled-coil domain containing 86 chr11 60610178 NM_024098 exon1 c.A581T p.E194V exonic 0.97 D ---+--- 1 FCGBP Fc fragment of IgG binding protein chr19 40368666 NM_003890 exon28 c.C12682G p.Q4228E exonic 0.97 D -+-----
Load more

Recommended publications
  • Screening of a Clinically and Biochemically Diagnosed SOD Patient Using Exome Sequencing: a Case Report with a Mutations/Variations Analysis Approach
    The Egyptian Journal of Medical Human Genetics (2016) 17, 131–136 HOSTED BY Ain Shams University The Egyptian Journal of Medical Human Genetics www.ejmhg.eg.net www.sciencedirect.com CASE REPORT Screening of a clinically and biochemically diagnosed SOD patient using exome sequencing: A case report with a mutations/variations analysis approach Mohamad-Reza Aghanoori a,b,1, Ghazaleh Mohammadzadeh Shahriary c,2, Mahdi Safarpour d,3, Ahmad Ebrahimi d,* a Department of Medical Genetics, Shiraz University of Medical Sciences, Shiraz, Iran b Research and Development Division, RoyaBioGene Co., Tehran, Iran c Department of Genetics, Shahid Chamran University of Ahvaz, Ahvaz, Iran d Cellular and Molecular Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran Received 12 May 2015; accepted 15 June 2015 Available online 22 July 2015 KEYWORDS Abstract Background: Sulfite oxidase deficiency (SOD) is a rare neurometabolic inherited disor- Sulfite oxidase deficiency; der causing severe delay in developmental stages and premature death. The disease follows an auto- Case report; somal recessive pattern of inheritance and causes deficiency in the activity of sulfite oxidase, an Exome sequencing enzyme that normally catalyzes conversion of sulfite to sulfate. Aim of the study: SOD is an underdiagnosed disorder and its diagnosis can be difficult in young infants as early clinical features and neuroimaging changes may imitate some common diseases. Since the prognosis of the disease is poor, using exome sequencing as a powerful and efficient strat- egy for identifying the genes underlying rare mendelian disorders can provide important knowledge about early diagnosis, disease mechanisms, biological pathways, and potential therapeutic targets.
    [Show full text]
  • Expression of the POTE Gene Family in Human Ovarian Cancer Carter J Barger1,2, Wa Zhang1,2, Ashok Sharma 1,2, Linda Chee1,2, Smitha R
    www.nature.com/scientificreports OPEN Expression of the POTE gene family in human ovarian cancer Carter J Barger1,2, Wa Zhang1,2, Ashok Sharma 1,2, Linda Chee1,2, Smitha R. James3, Christina N. Kufel3, Austin Miller 4, Jane Meza5, Ronny Drapkin 6, Kunle Odunsi7,8,9, 2,10 1,2,3 Received: 5 July 2018 David Klinkebiel & Adam R. Karpf Accepted: 7 November 2018 The POTE family includes 14 genes in three phylogenetic groups. We determined POTE mRNA Published: xx xx xxxx expression in normal tissues, epithelial ovarian and high-grade serous ovarian cancer (EOC, HGSC), and pan-cancer, and determined the relationship of POTE expression to ovarian cancer clinicopathology. Groups 1 & 2 POTEs showed testis-specifc expression in normal tissues, consistent with assignment as cancer-testis antigens (CTAs), while Group 3 POTEs were expressed in several normal tissues, indicating they are not CTAs. Pan-POTE and individual POTEs showed signifcantly elevated expression in EOC and HGSC compared to normal controls. Pan-POTE correlated with increased stage, grade, and the HGSC subtype. Select individual POTEs showed increased expression in recurrent HGSC, and POTEE specifcally associated with reduced HGSC OS. Consistent with tumors, EOC cell lines had signifcantly elevated Pan-POTE compared to OSE and FTE cells. Notably, Group 1 & 2 POTEs (POTEs A/B/B2/C/D), Group 3 POTE-actin genes (POTEs E/F/I/J/KP), and other Group 3 POTEs (POTEs G/H/M) show within-group correlated expression, and pan-cancer analyses of tumors and cell lines confrmed this relationship. Based on their restricted expression in normal tissues and increased expression and association with poor prognosis in ovarian cancer, POTEs are potential oncogenes and therapeutic targets in this malignancy.
    [Show full text]
  • Molecular Features of Triple Negative Breast Cancer Cells by Genome-Wide Gene Expression Profiling Analysis
    478 INTERNATIONAL JOURNAL OF ONCOLOGY 42: 478-506, 2013 Molecular features of triple negative breast cancer cells by genome-wide gene expression profiling analysis MASATO KOMATSU1,2*, TETSURO YOSHIMARU1*, TAISUKE MATSUO1, KAZUMA KIYOTANI1, YASUO MIYOSHI3, TOSHIHITO TANAHASHI4, KAZUHITO ROKUTAN4, RUI YAMAGUCHI5, AYUMU SAITO6, SEIYA IMOTO6, SATORU MIYANO6, YUSUKE NAKAMURA7, MITSUNORI SASA8, MITSUO SHIMADA2 and TOYOMASA KATAGIRI1 1Division of Genome Medicine, Institute for Genome Research, The University of Tokushima; 2Department of Digestive and Transplantation Surgery, The University of Tokushima Graduate School; 3Department of Surgery, Division of Breast and Endocrine Surgery, Hyogo College of Medicine, Hyogo 663-8501; 4Department of Stress Science, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima 770-8503; Laboratories of 5Sequence Analysis, 6DNA Information Analysis and 7Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo 108-8639; 8Tokushima Breast Care Clinic, Tokushima 770-0052, Japan Received September 22, 2012; Accepted November 6, 2012 DOI: 10.3892/ijo.2012.1744 Abstract. Triple negative breast cancer (TNBC) has a poor carcinogenesis of TNBC and could contribute to the develop- outcome due to the lack of beneficial therapeutic targets. To ment of molecular targets as a treatment for TNBC patients. clarify the molecular mechanisms involved in the carcino- genesis of TNBC and to identify target molecules for novel Introduction anticancer drugs, we analyzed the gene expression profiles of 30 TNBCs as well as 13 normal epithelial ductal cells that were Breast cancer is one of the most common solid malignant purified by laser-microbeam microdissection. We identified tumors among women worldwide. Breast cancer is a heteroge- 301 and 321 transcripts that were significantly upregulated neous disease that is currently classified based on the expression and downregulated in TNBC, respectively.
    [Show full text]
  • High-Resolution Analysis of Chromosomal Alterations in Adult Acute Lymphoblastic Leukemia
    Elmer Press Original Article J Hematol. 2014;3(3):65-71 High-Resolution Analysis of Chromosomal Alterations in Adult Acute Lymphoblastic Leukemia Lam Kah Yuena, c, Zakaria Zubaidaha, Ivyna Bong Pau Nia, Megat Baharuddin Puteri Jamilatul Noora, Esa Ezaliaa, Chin Yuet Menga, Ong Tee Chuanb, Vegappan Subramanianb, Chang Kiang Mengb Abstract Introduction Background: Chromosomal alterations occur frequently in acute Acute lymphoblastic leukemia (ALL) is a heterogeneous lymphoblastic leukemia (ALL), affecting either the chromosome disease, resulting from the accumulation of chromosomal al- number or structural changes. These alterations can lead to inacti- terations either in the form of numerical or structural chang- vation of tumor suppressor genes and/or activation of oncogenes. es such as amplification, deletion, inversion or translocation. The objective of this study was to identify recurrent and/or novel The frequency of chromosomal alterations in adult ALL is chromosomal alterations in adult ALL using single nucleotide poly- 64-85% [1], compared to 60-69% in childhood ALL. Trans- morphism (SNP) array analysis. location t(9.22), one of the most common recurring chromo- Methods: We studied 41 cases of adult ALL compared with healthy somal alterations, is found in 20-40% adult ALL patients [2], normal controls using SNP array. and its incidence increases with age. Some of the chromo- somal alterations are significantly associated with remission Results: Our analysis revealed 43 copy number variant regions, duration, complete remission rate and disease-free survival of which 44% were amplifications and 56% were deletions. The [1]. Increasing age is also associated with lower remission most common amplifications were on chromosome regions 8p23.1 rates, shorter remissions and poor outcomes in adult ALL (71%), 1q44 (66%), 1q23.3 (54%), 11q23.3 (54%), 12p13.33 [1].
    [Show full text]
  • Genome-Wide Analysis of Copy Number Variation in Type 1 Diabetes …………………………………………………………76
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by ETD - Electronic Theses & Dissertations GENE EXPRESSION AND COPY NUMBER VARIATION IN COMMON COMPLEX DISEASES By Britney L. Grayson Dissertation Submitted to the Faculty of the Graduate School of Vanderbilt University in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY in Microbiology and Immunology December, 2010 Nashville, Tennessee Approved: Thomas M. Aune Luc Van Kaer James W. Thomas Nancy J. Brown Marylyn D. Ritchie To my mom, Ruthie, your battle with lupus inspired every experiment on these pages. To my dad, Richard, a short pencil IS better than a long memory. To my sisters, Brandy and Brienne, I am but one-third of a whole. ii ACKNOWLEDGEMENTS I am thankful to my thesis committee, especially my mentor Tom Aune for his many hours of "interaction" and countless "pearls of wisdom." I am thankful to Luc Van Kaer for being an organized and timely chair and to all members, Drs. Aune, Van Kaer, Thomas, Ritchie and Brown, for insightful comments, critiques and advice that propelled both me and these projects forward. I am thankful for my lab members past and present- Kelly, Patrick, Zach, Erica, Sarah, Nyk, Chase, our honorary member, David and especially Mary Ellen, who performed many of the experiments you see on these pages, John, who helps to maintain our patient samples biobank and Mel, who had a solution to all of my lab problems. I am thankful to all of the physicians and clinics who gave of their time to recruit patients for these studies.
    [Show full text]
  • Testis Antigens Defines Obligate Participation in Multiple
    ARTICLE Received 11 May 2015 | Accepted 8 Oct 2015 | Published 16 Nov 2015 DOI: 10.1038/ncomms9840 OPEN Comprehensive functional characterization of cancer–testis antigens defines obligate participation in multiple hallmarks of cancer Kimberly E. Maxfield1,*, Patrick J. Taus1,2,*, Kathleen Corcoran3, Joshua Wooten2, Jennifer Macion1, Yunyun Zhou4, Mark Borromeo5, Rahul K. Kollipara6, Jingsheng Yan1, Yang Xie1,4, Xian-Jin Xie1,4 & Angelique W. Whitehurst1 Tumours frequently activate genes whose expression is otherwise biased to the testis, collectively known as cancer–testis antigens (CTAs). The extent to which CTA expression represents epiphenomena or confers tumorigenic traits is unknown. In this study, to address this, we implemented a multidimensional functional genomics approach that incorporates 7 different phenotypic assays in 11 distinct disease settings. We identify 26 CTAs that are essential for tumor cell viability and/or are pathological drivers of HIF, WNT or TGFb signalling. In particular, we discover that Foetal and Adult Testis Expressed 1 (FATE1) is a key survival factor in multiple oncogenic backgrounds. FATE1 prevents the accumulation of the stress-sensing BH3-only protein, BCL-2-Interacting Killer (BIK), thereby permitting viability in the presence of toxic stimuli. Furthermore, ZNF165 promotes TGFb signalling by directly suppressing the expression of negative feedback regulatory pathways. This action is essential for the survival of triple negative breast cancer cells in vitro and in vivo. Thus, CTAs make significant direct contributions to tumour biology. 1 Simmons Comprehensive Cancer Center, UT-Southwestern Medical Center, Dallas, Texas 75390, USA. 2 Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.
    [Show full text]
  • Based Medicine in Breast Cancer
    Towards pathway and network- based medicine in breast cancer Himanshu Joshi Faculty of Medicine Institute of Clinical Medicine University of Oslo Oslo © Himanshu Joshi, 2014 Series of dissertations submitted to the Faculty of Medicine, University of Oslo No. 1734 ISBN 978-82-8264-820-2 All rights reserved. No part of this publication may be reproduced or transmitted, in any form or by any means, without permission. Cover: Inger Sandved Anfinsen. Printed in Norway: AIT Oslo AS. Produced in co-operation with Akademika Publishing. The thesis is produced by Akademika Publishing merely in connection with the thesis defence. Kindly direct all inquiries regarding the thesis to the copyright holder or the unit which grants the doctorate. Abstract Introduction Breast cancer is a molecularly heterogeneous disease. The existing molecular classifications provide a good introduction of the molecular heterogeneity. However more efforts are necessary to characterize molecularly distinct tumor subgroups that are likely responders to novel targeted therapy interventions. One of the classification strategies is to characterize robust classes based on activity of specific biological pathways and networks. This thesis describes a classification based on activity status of p53, ER and VEGF signaling in breast cancer. Methods In paper I, canonical sequences from the proximal promoter of the genes that distinguish the molecular portraits are studied to identify the significantly overrepresented potential TFBS motifs for each molecular class. Subtype-specific networks based on previously reported or predicted interactions between subtype- specific genes and corresponding transcription factors. In paper II, breast cancer expression profiles were analyzed for inferring differentially activated pathways and differentially expressed genes by p53 gene mutation status using geneset-based and individual gene search methods.
    [Show full text]
  • Chromosomal Imbalances in Patients with Congenital Cardiac Defects: a Meta-Analysis Reveals Novel Potential Critical Regions Involved in Heart Development
    193 ORIGINAL ARTICLES Chromosomal Imbalances in Patients with Congenital Cardiac Defects: A Meta-analysis Reveals Novel Potential Critical Regions Involved in Heart Development Thor Thorsson, MD,* William W. Russell,* Nour El-Kashlan,* Rachel Soemedi, PhD,† Jonathan Levine,* Sarah B. Geisler, MS,* Todd Ackley, PhD,‡ Aoy Tomita-Mitchell, PhD,§ Jill A. Rosenfeld, MS, CGC,¶ Ana Töpf, PhD,** Marwan Tayeh, PhD,‡ Judith Goodship, PhD,** Jeffrey W. Innis, MD, PhD,‡†† Bernard Keavney, MD,‡‡ and Mark W. Russell, MD* Department of Pediatrics and Communicable Diseases, Divisions of *Pediatric Cardiology and ‡Pediatric Genetics, University of Michigan, Ann Arbor, Mich, USA; †Center for Computational Molecular Biology, Brown University, Providence, RI, USA; §Department of Surgery, Medical College of Wisconsin, Milwaukee, Wis, USA; ¶Signature Genomic Laboratories, PerkinElmer, Inc., Spokane, Wash, USA; **Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom; ††Department of Human Genetics, University of Michigan, Ann Arbor, Mich, USA; ‡‡Institute of Cardiovascular Sciences, Central Manchester University, Manchester, United Kingdom ABSTRACT Objective. Congenital cardiac defects represent the most common group of birth defects, affecting an estimated six per 1000 births. Genetic characterization of patients and families with cardiac defects has identified a number of genes required for heart development. Yet, despite the rapid pace of these advances, mutations affecting known genes still account for only a small fraction of congenital heart defects suggesting that many more genes and developmental mechanisms remain to be identified. Design. In this study, we reviewed 1694 described cases of patients with cardiac defects who were determined to have a significant chromosomal imbalance (a deletion or duplication). The cases were collected from publicly available databases (DECIPHER, ISCA, and CHDWiki) and from recent publications.
    [Show full text]
  • Evolutionary Dynamics of the POTE Gene Family in Human and Nonhuman Primates
    G C A T T A C G G C A T genes Article Evolutionary Dynamics of the POTE Gene Family in Human and Nonhuman Primates Flavia Angela Maria Maggiolini 1 , Ludovica Mercuri 1, Francesca Antonacci 1, Fabio Anaclerio 1, Francesco Maria Calabrese 1 , Nicola Lorusso 1, Alberto L’Abbate 2, Melanie Sorensen 3, Giuliana Giannuzzi 4, Evan E. Eichler 3,5, Claudia Rita Catacchio 1,* and Mario Ventura 1,* 1 Department of Biology, University of Bari ‘Aldo Moro’, 70125 Bari, Italy; fl[email protected] (F.A.M.M.); [email protected] (L.M.); [email protected] (F.A.); [email protected] (F.A.); [email protected] (F.M.C.); [email protected] (N.L.) 2 Institute of Biomembranes, Bioenergetics, and Molecular Biotechnologies—National Research Council (IBIOM-CNR), 70125 Bari, Italy; [email protected] 3 Department of Genome Sciences, University of Washington School of Medicine, Seattle, Wa 98195, USA; [email protected] (M.S.); [email protected] (E.E.E.) 4 Center for Integrative Genomics, University of Lausanne, 1015 Lausanne, Switzerland; [email protected] 5 Howard Hughes Medical Institute, University of Washington, Seattle, Wa 98195, USA * Correspondence: [email protected] (C.R.C.); [email protected] (M.V.) Received: 17 December 2019; Accepted: 13 February 2020; Published: 18 February 2020 Abstract: POTE (prostate, ovary, testis, and placenta expressed) genes belong to a primate-specific gene family expressed in prostate, ovary, and testis as well as in several cancers including breast, prostate, and lung cancers. Due to their tumor-specific expression, POTEs are potential oncogenes, therapeutic targets, and biomarkers for these malignancies.
    [Show full text]
  • Accurate Mutation Annotation and Functional Prediction Enhance the Applicability of -Omics Data in Precision Medicine
    The Texas Medical Center Library DigitalCommons@TMC The University of Texas MD Anderson Cancer Center UTHealth Graduate School of The University of Texas MD Anderson Cancer Biomedical Sciences Dissertations and Theses Center UTHealth Graduate School of (Open Access) Biomedical Sciences 5-2016 Accurate mutation annotation and functional prediction enhance the applicability of -omics data in precision medicine Tenghui Chen Follow this and additional works at: https://digitalcommons.library.tmc.edu/utgsbs_dissertations Part of the Bioinformatics Commons, Computational Biology Commons, Genomics Commons, and the Medicine and Health Sciences Commons Recommended Citation Chen, Tenghui, "Accurate mutation annotation and functional prediction enhance the applicability of -omics data in precision medicine" (2016). The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access). 666. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/666 This Dissertation (PhD) is brought to you for free and open access by the The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at DigitalCommons@TMC. It has been accepted for inclusion in The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access) by an authorized administrator of DigitalCommons@TMC. For more information, please contact [email protected]. ACCURATE MUTATION ANNOTATION AND FUNCTIONAL PREDICTION
    [Show full text]
  • High-Resolution DNA Analysis of Human Embryonic Stem Cell Lines Reveals Culture-Induced Copy Number Changes and Loss of Heterozygosity
    RESOURCE High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity Elisa Närvä1, Reija Autio1,2, Nelly Rahkonen1, Lingjia Kong2, Neil Harrison3, Danny Kitsberg4, Lodovica Borghese5, Joseph Itskovitz-Eldor6, Omid Rasool1, Petr Dvorak7, Outi Hovatta8, Timo Otonkoski9,10, Timo Tuuri9, Wei Cui11, Oliver Brüstle5, Duncan Baker12, Edna Maltby12, Harry D Moore13, Nissim Benvenisty14, Peter W Andrews3, Olli Yli-Harja2,15 & Riitta Lahesmaa1 Prolonged culture of human embryonic stem cells (hESCs) can lead to adaptation and the acquisition of chromosomal abnormalities, underscoring the need for rigorous genetic analysis of these cells. Here we report the highest-resolution study of hESCs to date using an Affymetrix SNP 6.0 array containing 906,600 probes for single nucleotide polymorphisms (SNPs) and 946,000 probes for copy number variations (CNVs). Analysis of 17 different hESC lines maintained in different laboratories identified 843 CNVs of 50 kb–3 Mb in size. We identified, on average, 24% of the loss of heterozygosity (LOH) sites and 66% of the CNVs changed in culture between early and late passages of the same lines. Thirty percent of the genes detected within CNV sites had altered expression compared to samples with normal copy number states, of which >44% were functionally linked to cancer. Furthermore, LOH of the q arm of chromosome 16, which has not been observed previously in hESCs, was detected. Pluripotent hESCs are studied for potential applications in regenera- human genome variability. Specific recurrent CNVs are common in tive medicine because of their unique capacity to self-renew and to tumors10,11; particular tumor types have characteristic copy number differentiate into any cell type.
    [Show full text]
  • The Identification of a Novel Fucosidosis-Associated
    G C A T T A C G G C A T genes Article The Identification of a Novel Fucosidosis-Associated FUCA1 Mutation: A Case of a 5-Year-Old Polish Girl with Two Additional Rare Chromosomal Aberrations and Affected DNA Methylation Patterns Agnieszka Domin 1,†, Tomasz Zabek 2,† , Aleksandra Kwiatkowska 3,† , Tomasz Szmatola 2,4,† , Anna Deregowska 5, Anna Lewinska 5 , Artur Mazur 1,* and Maciej Wnuk 5,* 1 Department of Pediatrics and Pediatric Endocrinology and Diabetes, University of Rzeszow, Aleja Rejtana 16c, 35-959 Rzeszow, Poland; [email protected] 2 National Research Institute of Animal Production, Krakowska 1, 32-083 Balice, Poland; [email protected] (T.Z.); [email protected] (T.S.) 3 Laboratory of Exercise Physiology and Biochemistry, Institute of Physical Culture Studies, College of Medical Sciences, University of Rzeszow, Aleja Rejtana 16c, 35-959 Rzeszow, Poland; [email protected] 4 University Centre of Veterinary Medicine, University of Agriculture in Krakow, Al. Mickiewicza 24/28, 30-059 Krakow, Poland 5 Department of Biotechnology, University of Rzeszow, Aleja Rejtana 16c, 35-959 Rzeszow, Poland; [email protected] (A.D.); [email protected] (A.L.) * Correspondence: [email protected] (A.M.); [email protected] (M.W.) † These authors have contributed equally as first authors. Abstract: Fucosidosis is a rare neurodegenerative autosomal recessive disorder, which manifests Citation: Domin, A.; Zabek, T.; as progressive neurological and psychomotor deterioration, growth retardation, skin and skeletal Kwiatkowska, A.; Szmatola, T.; abnormalities, intellectual disability and coarsening of facial features. It is caused by biallelic muta- Deregowska, A.; Lewinska, A.; Mazur, α A.; Wnuk, M.
    [Show full text]